Wang, H., Liang, Y., Liu, Z., Zhang, R., Chao, J., Wang, M., Liu, M., Qiao, L., Xuan, Z., Zhao, H., Lu, L.

POSTN+ cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma

27 de July de 2024 by Wang, H., Liang, Y., Liu, Z., Zhang, R., Chao, J., Wang, M., Liu, M., Qiao, L., Xuan, Z., Zhao, H., Lu, L.

Objective
Hepatocellular carcinoma (HCC) poses a significant clinical challenge because the long-term benefits of immune checkpoint blockade therapy are limited. A comprehensive understanding of the mechanisms underlying immunotherapy resistance in HC…